Intrinsiqq
Observe Medical ASA logo

Observe Medical ASA

OBSRV.XOSL

Compare

Valuation & Multiples

Based on TTM earnings · Diluted shares

Market CapNOK 48M
EPS-NOK 0.73
P/E-0.09
P/FCF-1.85
EV/EBITDA-1.80
FCF Yield–
Div. Yield–
Net Debt/FCF-0.7x
Observe Medical ASA intrinsic value
52-Week Range
€0.04€0.11

Profitability & Returns

Revenue (TTM)

NOK 19M

▲ +9.2% YoY

Net Income (TTM)

-NOK 49M

▲ +17.2% YoY

Op. Margin

-198.50%

▲ +59.2pp YoY

ROIC

-35.72%

▼ -0.9pp YoY

Cash Flow & Balance Sheet

FCF (TTM)

-NOK 26M

▲ +11.3% YoY

Op. Cash Flow (TTM)

-NOK 25M

▲ +12.0% YoY

Net Debt

NOK 19M

Cash & Equiv.

NOK 12M

3Y CAGR: -1.2%

Continue Research

Peers

Medical Devices · Pick stocks to compare with OBSRV.XOSL

CompareIntrinsic value
ONCIN.XOSLOncoinvent ASA
No recent price50
CODE.XOSLCodeLab Capital AS
€0.43+1.19%20
ABS.XOSLArctic Bioscience ASA
€0.21-2.80%26
NORDH.XOSLNordhealth AS
€2.36+4.42%48
CONTX.XOSLContextVision AB
kr 4.69+5.87%36
AZT.XOSLArcticZymes Technologies ASA
€2.11+3.43%23
GENT.XOSLGentian Diagnostics ASA
€3.70-0.54%63
IVACC.XSTOIntervacc AB
€0.05+1.59%40

Observe Medical ASA (OBSRV.XOSL) in four numbers

Fair value (revenue)
€0.03
Price €0.07 is 157% above it.
Intrinsic Value
Quality score
15/100
Best check: margin trend, +104.5pp. Weakest: return on capital, -35.7%.
Quality
Dividend
None
No dividend in the company filings we hold.
Dividends
P/E
-0.09
Negative: a loss over the last twelve months. Price to free cash flow -1.85.
Financials

Questions about Observe Medical ASA

Is Observe Medical ASA (OBSRV.XOSL) overvalued?

At €0.07, Observe Medical ASA's price is 157% above the €0.03 a share fair value that Intrinsiqq's calculator gets from its revenue. The growth behind that figure is yours to set on the Intrinsic Value tab. See how to tell if a stock is overvalued.

What is Observe Medical ASA's fair value?

Intrinsiqq's calculator puts Observe Medical ASA's fair value at €0.03 a share. It grows revenue per share 0% a year for 5 years, applies an exit P/S of 1.6, and works back at a 10% yearly return. A 25% margin of safety gives a buy-below price of €0.02. Every input can be changed on the Intrinsic Value tab.

Is Observe Medical ASA a high-quality business?

Observe Medical ASA scores 15 out of 100 on Intrinsiqq's quality score, which makes it a lower-quality business on these measures. The score blends 6 checks computed from company filings. Its best check is margin trend at +104.5pp, and its weakest is return on capital at -35.7%. The Quality tab shows every check against its target.

Does Observe Medical ASA (OBSRV.XOSL) pay a dividend?

No. Observe Medical ASA (OBSRV.XOSL) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.

Source: company filings. Price: last close 11 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing OBSRV.XOSL

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.